ArticleACS omega2025
Preparation and Characterization of Novel Hydroxyapatite/Montmorillonite/Gelatin-Based Composites with Bone Remineralizing Potential.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development of a Nano-Hybrid Composite Using Bovine Hydroxyapatite and Montmorillonite for Endodontic Applications-An In Vitro Study.International endodontic journal · 2026Article
- Micro- and Nano-Structuring of Hydroxyapatite-MMT-Loaded Hydrogels for Bone Regeneration Applications.Journal of functional biomaterials · 2026Article
- Advances in biomimetic mineralized biomaterials for bone tissue engineering.Regenerative biomaterials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone wear caused by injury or deterioration due to age leads to the use of autologous and allogeneic implants that are sometimes rejected by the body. Currently, work is being carried out on the development of composites that induce bone repair. In this study, composites with montmorillonite clay (MMT), hydroxyapatite (HAp), and gelatin were prepared. Initially, various ratios of HAp/MMT composites (1:1, 2:1, and 1:2) were examined, and the 2:1 ratio provided a better biological response. Finally, the HAp/MMT/Gel ternary mixtures were prepared using different percentages of gelatin: 10, 50, and 90% and maintaining the 2:1 HAp/MMT ratio. All materials were assayed in a biomineralization proof using simulated biological fluids. In the HAp/MMT/Gel diffraction pattern, the peaks associated with MMT and HAp are preserved at 20 and 32° in 2θ, respectively; the addition of gelatin promotes structural changes. Biocompatibility studies show that there are no morphological changes in the platelets since it does not exceed 5 μm of pseudopodia, which suggests that there is no rejection of the material. On the other hand, the biomineralization study, followed by SEM and FTIR characterization, showed the generation of apatite and demonstrated its potential application in bone tissue regeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.